[1]吴宇,朱馨艺,江洪祥,等.秋水仙碱对胶质瘤细胞系化疗敏感性的影响[J].中国临床神经外科杂志,2024,29(02):97-104.[doi:10.13798/j.issn.1009-153X.2024.02.008]
　WU Yu,ZHU Xin-yi,JIANG Hong-xiang,et al.Effect of colchicine on the sensitivity of glioma cells to temozolomide chemotherapy[J].,2024,29(02):97-104.[doi:10.13798/j.issn.1009-153X.2024.02.008]
点击复制

秋水仙碱对胶质瘤细胞系化疗敏感性的影响()

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
29
期数:
2024年02期
页码:
97-104
栏目:
实验研究
出版日期:
2024-02-28

文章信息/Info

Title:
Effect of colchicine on the sensitivity of glioma cells to temozolomide chemotherapy
文章编号:
1009-153X（2024）02-0097-08
作者:
吴宇; 朱馨艺; 江洪祥; 陈谦学
430060武汉，武汉大学人民医院神经外科（吴宇、朱馨艺、江洪祥、陈谦学）
Author(s):
WU Yu;  ZHU Xin-yi;  JIANG Hong-xiang;  CHEN Qian-xue
Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China
关键词:
胶质瘤; U87细胞; A172细胞; 替莫唑胺; 秋水仙碱; 化疗敏感性
Keywords:
Glioma;  U87 cells;  A172 cells;  Temozolomide;  Colchicine;  Chemotherapy sensitivity
分类号:
R 739.41
DOI:
10.13798/j.issn.1009-153X.2024.02.008
文献标志码:
A
摘要:
目的 探讨秋水仙碱对胶质瘤细胞系化疗敏感性的影响及其机制。方法 采用不同浓度的替莫唑胺（TMZ）处理人脑胶质瘤细胞系U87和A172细胞，构建TMZ耐药细胞系U87/TR和A172/TR，再使用秋水仙碱（10、30 ng/ml）干预1、2、3 d，采用细胞计数法、BrdU法和流式细胞术检测细胞活力、细胞增殖和细胞周期。生物信息学方法分析胶质瘤组织差异表达的微小RNA（miRNAs），并预测其靶基因；然后，采用qRT-PCR检测U-87/TR和A172/TR细胞中这些miRNAs的表达情况，调控miRNAs的表达以观察秋水仙碱效应的变化。结果 秋水仙碱显著抑制U87/TR和A172/TR细胞的增殖活力（P<0.05），呈时间依赖性和剂量依赖性（P<0.05），而且显著阻滞U87/TR和A172/TR的有丝分裂，使细胞阻滞在G0/G1期。30 ng/ml秋水仙碱显著增加TMZ对U87/TR和A172/TR细胞增殖的抑制效果（P<0.05），明显降低TMZ的IC50值（P<0.05）。生信分析显示，胶质瘤组织miR-330-3p、miR-491-5p、miR-6782-5p、miR-31-5p、miR-330-5p、miR-137和miR-433-3p呈差异表达，秋水仙碱明显上调U87/TR和A172/TR细胞miR-330-3p的表达（P<0.05）、明显抑制miR-330-3p靶基因ErbB的表达（P<0.05）。抑制miR-330-3p表达明显逆转秋水仙碱的生物学效应（P<0.05）。结论 秋水仙碱可以抑制TMZ耐药的胶质瘤细胞的增殖，其机制可能涉及到miR-330-3p/ErbB信号通路的调节。
Abstract:
Objective To investigate the effect of colchicine on the sensitivity of glioma cells to temozolomide (TMZ) chemotherapy and its mechanism. Methods Different concentrations of TMZ were used to treat human glioma cell lines U87 and A172, and to construct TMZ-resistant cell lines U87/TR and A172/TR. After colchicine (10, 30 ng/ml) treatment for 1, 2, and 3 days, cell viability, cell proliferation, and cell cycle were detected by cell counting, BrdU method, and flow cytometry, respectively. The differentially expressed microRNAs (miRNAs) in glioma tissues were analyzed by bioinformatics methods, and their target genes were predicted. Then, qRT-PCR was used to detect the expression of these miRNAs in U87/TR and A172/TR cells, and the expression of miRNAs was regulated to observe the changes of colchicine effects. Results Colchicine significantly inhibited the proliferation of U87/TR and A172/TR cells (P<0.05), with time- and dose-dependent manners (P<0.05). Colchicine significantly blocked mitosis of U87/TR and A172/TR cells, and induced cell cycle arrest in the G0/G1 Phase. Colchicine at the concentration of 30 ng/ml significantly increased the inhibitory effect of TMZ on proliferation of U87/TR and A172/TR cells (P<0.05), and significantly reduced the IC50 value of TMZ (P<0.05). Bioinformatics analysis showed that miR-330-3p, miR-491-5p, miR-6782-5p, miR-31-5p, miR-330-5p, miR-137, and miR-433-3p were differentially expressed in glioma tissues. Colchicine significantly upregulated the expression of miR-330-3p in U87/TR and A172/TR cells (P<0.05), and significantly inhibited the expression of miR-330-3p target gene ErbB (P<0.05). Inhibition of miR-330-3p significantly reversed the biological effects of colchicine (P<0.05). Conclusions Colchicine can inhibit the proliferation of TMZ-resistant glioma cells, and the mechanism may be involved in the regulation of miR-330-3p/ErbB signaling pathway.

参考文献/References:

[1]XU S, TANG L, LI X, et al. Immunotherapy for glioma: current management and future application [J]. Cancer Lett, 2020, 476: 1-12.
[2]BUSH NA, CHANG SM, BERGER M S. Current and future strate-gies for treatment of glioma [J]. Neurosurg Rev, 2017, 40(1): 1-14.
[3]TANG JH, YANG L, CHEN J X, et al. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis [J]. Cancer Commun (Lond), 2019, 39(1): 81.
[4]PATRIZZ A, DONO A, ZOROFCHIAN S, et al. Glioma and temo-zolomide induced alterations in gut microbiome [J]. Sci Rep, 2020, 10(1): 21002.
[5]GHAWANMEH AA, CHONG KF, SARKAR SM, et al. Colchicine prodrugs and codrugs: chemistry and bioactivities [J]. Eur J Med Chem, 2018, 144: 229-242.
[6]AWAD AS, ELARINY HA, SALLAM AS. The possible protective effect of colchicine against liver damage induced by renal ischemia-reperfusion injury: role of Nrf2 and NLRP3 inflammasome [J]. Can J Physiol Pharmacol, 2020, 98(12): 849-854.
[7]HUANG CG, GUO ZT, CHEN QX, et al. The cell cycle and P-gly-coprotein expression changes of drug-resistance cell lines of U251 induced by temozolomide after radiation exposure [J]. Chin J Exp Surg, 2014, 31(9): 1883-1885.
黄从刚，郭振涛，陈谦学，等. 胶质瘤U251耐替莫唑胺细胞株放射照射后细胞周期及P-糖蛋白表达变化[J]. 中华实验外科杂志，2014，31（9）：1883-1885.
[8]XIONG L, WANG F, QI X. Advanced treatment in high-grad gliomas [J]. J Buon, 2019, 24(2): 424-230.
[9]TOM MC, CAHILL DP, BUCKNER JC, et al. Management for differ-ent glioma subtypes: are all low-grade gliomas created equal [J]. Am Soc Clin Oncol Educ Book, 2019, 39: 133-145.
[10] DING C, YI X, WU X, et al. Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma [J]. Cancer Lett, 2020, 479: 1-12.
[11] YAN L, HUANG H, ZHANG Y, et al. Involvement of p53-depen-dent apoptosis signal in antitumor effect of Colchicine on human papilloma virus (HPV)-positive human cervical cancer cells [J]. Biosci Rep, 2020, 40(3): BSR20194065.
[12] DUAN Y, LIU W, TIAN L, et al. Targeting tubulin-colchicine site for cancer therapy: inhibitors, antibody-drug conjugates and degradation agents [J]. Curr Top Med Chem, 2019, 19(15): 1289-1304.
[13] JOHNSON L, GOPING IS, RIEGER A, et al. Novel colchicine deri-vatives and their anti-cancer activity [J]. Curr Top Med Chem, 2017, 17(22): 2538-2558.
[14] SUN Y, LIN X, CHANG H. Proliferation inhibition and apoptosis of breast cancer MCF-7 cells under the influence of colchicine [J]. J Buon, 2016, 21(3): 570-575.
[15] CHO JH, JOO YH, SHIN EY, et al. Anticancer effects of colchicine on hypopharyngeal cancer [J]. Anticancer Res, 2017, 37(11): 6269-6280.
[16] FANG KM, LIU JJ, LI CC, et al. Colchicine derivative as a potential anti-glioma compound [J]. J Neurooncol, 2015, 124(3): 403-412.
[17] RUPAIMOOLE R, SLACK FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases [J]. Nat Rev Drug Discov, 2017, 16(3): 203-222.
[18] WANG H, LIU G, LI T, et al. MiR-330-3p functions as a tumor suppressor that regulates glioma cell proliferation and migration by targeting CELF1 [J]. Arch Med Sci, 2020, 16(5): 1166-1175.
[19] ZHU B, LIU W, LIU H, et al. LINC01094 down-regulates miR-330-3p and enhances the expression of MSI1 to promote the pro-gression of glioma [J]. Cancer Manag Res, 2020, 12: 6511-6521.
[20] WANG Z. ErbB receptors and cancer [J]. Methods Mol Biol, 2017, 1652: 3-35.
[21] OPRITA A, BALOI SC, STAICU GA, et al. Updated insights on EGFR signaling pathways in glioma [J]. Int J Mol Sci, 2021, 22(2): 587.
[22] LIU Y, YANG L, LIAO F, et al. MiR-450a-5p strengthens the drug sensitivity of gefitinib in glioma chemotherapy via regulating auto-phagy by targeting EGFR [J]. Oncogene, 2020, 39(39): 6190-6202.
[23] ZHOU XY, LIU H, DING ZB, et al. lncRNA SNHG16 promotes glioma tumorigenicity through miR-373/EGFR axis by activating PI3K/AKT pathway [J]. Genomics, 2020, 112(1): 1021-1029.

相似文献/References:

[1]常英男　王　策　赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
　CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(02):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛　克　陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许　耿　路俊锋　杨　忠　施建斌　吴秋月　王　烨　庄冬晓　吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
　XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(02):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰　陈银生　赛　克　张湘衡　柯　超　杨群英　牟永告　许海雄　陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
　LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(02):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波　杨宇焦　张　逵　范润金　张　渊　杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性 癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
　YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(02):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚　成于思　王　辉　汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞 增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
　HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(02):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林　雨　张　恺　李　帅　杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明　徐成仕　王泽芬　曹长军　李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
　DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(02):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生　田道锋　张申起　陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
　PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(02):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯　驰　郭双毅　程龙海　罗　杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
　FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(02):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
[11]胡　森　张　慧　步星耀　冯淼淼　王帮庆　王君毅　杨　斌　杨华超.白藜芦醇对裸鼠胶质瘤模型肿瘤生长的抑制作用[J].中国临床神经外科杂志,2019,(09):543.[doi:10.13798/j.issn.1009-153X.2019.09.010]
　HU Sen,ZHANG Hui,BU Xing-yao,et al.Resveratrol inhibits tumor growth in nude mice model of glioma[J].,2019,(02):543.[doi:10.13798/j.issn.1009-153X.2019.09.010]
[12]赵海康　潘　力　张　亮　冯小云　刘建荣　蒋小兵　高文文　马廉亭.替莫唑胺通过TFRC抑制U87胶质瘤细胞增殖和侵袭[J].中国临床神经外科杂志,2019,(11):685.[doi:10.13798/j.issn.1009-153X.2019.11.015]
　ZHAO Hai-kang,PAN Li,ZHANG Liang,et al.Temozolomide inhibits proliferation and invasion of glioma U87 cells by down-regulation of TFRC[J].,2019,(02):685.[doi:10.13798/j.issn.1009-153X.2019.11.015]
[13]任光辉　李武雄　齐利豪.胶质瘤干细胞外泌体通过PI3K/Akt信号通路促进胶质瘤U87细胞侵袭、迁移[J].中国临床神经外科杂志,2021,26(03):176.[doi:10.13798/j.issn.1009-153X.2021.03.011]
　REN Guang-hui,LI Wu-xiong,QI Li-hao.Glioma stem cell-derived exosomes promote glioma U87 cell invasion and migration through PI3K/Akt signaling pathway[J].,2021,26(02):176.[doi:10.13798/j.issn.1009-153X.2021.03.011]
[14]潘　轲　向春晖　周　龙　汪　逵　王国堰.FOXC2过表达通过激活Wnt/β-catenin信号通路促进胶质瘤U87细胞增殖、迁移[J].中国临床神经外科杂志,2021,26(04):266.[doi:10.13798/j.issn.1009-153X.2021.04.013]
　PAN Ke,XIANG Chun-hui,ZHOU Long,et al.FOXC2 overexpression promotes proliferation, invasion and migration of glioma U87 cells via activation of Wnt/β-catenin signaling pathway[J].,2021,26(02):266.[doi:10.13798/j.issn.1009-153X.2021.04.013]
[15]姜　羽　吕国伟　张文进等.槐定碱通过Wnt/β-catenin信号通路抑制人胶质瘤U87细胞迁移、侵袭[J].中国临床神经外科杂志,2021,26(10):789.[doi:10.13798/j.issn.1009-153X.2020.10.013]
　JIANG Yu,Lü Guo-wei,ZHANG Wen-jin,et al.Sophoridine inhibits migration and invasion of human glioma U87 cells by inhibting Wnt/β-catenin signaling pathway[J].,2021,26(02):789.[doi:10.13798/j.issn.1009-153X.2020.10.013]
[16]王昆鹏,张建党,董孟宁,等.lncRNA SNHG7对胶质瘤细胞侵袭、迁移的影响[J].中国临床神经外科杂志,2022,27(08):662.[doi:10.13798/j.issn.1009-153X.2022.08.012]
　WANG Kun-peng,ZHANG Jian-dang,DONG Meng-ning,et al.[J].,2022,27(02):662.[doi:10.13798/j.issn.1009-153X.2022.08.012]
[17]陶祥,张文斐,冀保卫,等.抑制SSRP1对胶质瘤细胞增殖、化疗敏感性的影响[J].中国临床神经外科杂志,2022,27(09):760.[doi:10.13798/j.issn.1009-153X.2022.09.013]
　TAO Xiang,ZHANG Wen-fei,JI Bao-wei,et al.Effect of inhibition of SSRP1 on glioma cells proliferation and chemosensitivity to temozolomide[J].,2022,27(02):760.[doi:10.13798/j.issn.1009-153X.2022.09.013]
[18]李继强,段发亮,吴京雷,等.下调BAG3表达对胶质瘤U87细胞增殖和凋亡的影响[J].中国临床神经外科杂志,2022,27(11):913.[doi:10.13798/j.issn.1009-153X.2022.11.010]
　LI Ji-qiang,DUAN Fa-liang,WU Jing-lei,et al.Effect of down-regulation of BAG3 on proliferation and apoptosis of glioma U87 cells[J].,2022,27(02):913.[doi:10.13798/j.issn.1009-153X.2022.11.010]
[19]热斯江·居马色衣提,张丽娜,秦虎,等.下调RNA甲基化酶NSUN2表达对脑胶质瘤U87细胞增殖、侵袭、迁移的影响[J].中国临床神经外科杂志,2023,28(02):102.[doi:10.13798/j.issn.1009-153X.2023.02.012]
　RESIJIANG Jumaseyiti,ZHANG Li-na,QIN Hu,et al.Effects of down-regulated expression of RNA methylase NSUN2 on proliferation, invasion, and migration of glioma U87 cells[J].,2023,28(02):102.[doi:10.13798/j.issn.1009-153X.2023.02.012]

备注/Memo

备注/Memo:
（2023-09-28收稿，2024-02-06修回） 通信作者：陈谦学，Email：chenqx666@whu.edu.cn
更新日期/Last Update: 2024-02-28